HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

tafenoquine

structure given in first source; RN given refers to parent cpd
Also Known As:
N(4)-(2,6-dimethoxy-4-methyl-5-((3-trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine; WR 238605; WR-238605; tafenoquine maleate; tafenoquine succinate; Butanedioic acid, compd. with N4-(2,6-dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine (1:1)
Networked: 47 relevant articles (12 outcomes, 13 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Edstein, Michael D: 5 articles (02/2010 - 12/2003)
2. Edstein, M D: 4 articles (11/2008 - 01/2001)
3. Green, Justin A: 3 articles (10/2015 - 03/2014)
4. Smith, Bryan: 3 articles (07/2015 - 01/2014)
5. Duparc, Stephan: 3 articles (09/2014 - 12/2013)
6. Miller, Ann K: 3 articles (09/2014 - 08/2007)
7. Ohrt, Colin: 3 articles (12/2013 - 02/2010)
8. Kocisko, D A: 3 articles (11/2008 - 12/2001)
9. Nasveld, P E: 3 articles (11/2008 - 01/2001)
10. Nasveld, Peter: 3 articles (03/2007 - 11/2002)

Related Diseases

1. Malaria
2. Infection
3. Vivax Malaria
4. Falciparum Malaria (Plasmodium falciparum Malaria)
5. Parasitemia

Related Drugs and Biologics

1. tafenoquine
2. Primaquine
3. Mefloquine (Lariam)
4. Chloroquine (Aralen)
5. Antimalarials (Antimalarial Agents)
6. Decoquinate
7. NITD 609
8. ferroquine
9. benzothiophene
10. usnic acid

Related Therapies and Procedures

1. Chemoprevention
2. Drug-Eluting Stents
3. Stents